LONDON – Having become popular with both celebrities and investors, diabetes drugs that also promote weight loss, such as Novo Nordisk’s Ozempic, are now being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease.
Diabetes regimens,…
Source: www.japantimes.co.jp – Read more

Are organisations leaving non-technical teams exposed in a cyber crisis? – The AI Journal
Are organisations leaving non-technical teams exposed in a cyber crisis? The AI Journal


